ATE161962T1 - Immunoassays unter verwendung von, mit meerrettich-peroxidase markierten carbamazepin- analogen - Google Patents

Immunoassays unter verwendung von, mit meerrettich-peroxidase markierten carbamazepin- analogen

Info

Publication number
ATE161962T1
ATE161962T1 AT93202292T AT93202292T ATE161962T1 AT E161962 T1 ATE161962 T1 AT E161962T1 AT 93202292 T AT93202292 T AT 93202292T AT 93202292 T AT93202292 T AT 93202292T AT E161962 T1 ATE161962 T1 AT E161962T1
Authority
AT
Austria
Prior art keywords
immunoassay
carbamazepine
horserad
peroxidase
labeled
Prior art date
Application number
AT93202292T
Other languages
English (en)
Inventor
Barbara Ann Brummond
Mohan Singh Saini
Ignazio Salvatore Ponticello
Original Assignee
Johnson & Johnson Clin Diag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/926,202 external-priority patent/US5578457A/en
Priority claimed from US07/926,203 external-priority patent/US5543311A/en
Application filed by Johnson & Johnson Clin Diag filed Critical Johnson & Johnson Clin Diag
Application granted granted Critical
Publication of ATE161962T1 publication Critical patent/ATE161962T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
    • C07D223/22—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/535—Production of labelled immunochemicals with enzyme label or co-enzymes, co-factors, enzyme inhibitors or enzyme substrates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9486—Analgesics, e.g. opiates, aspirine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT93202292T 1992-08-07 1993-08-04 Immunoassays unter verwendung von, mit meerrettich-peroxidase markierten carbamazepin- analogen ATE161962T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/926,202 US5578457A (en) 1992-08-07 1992-08-07 Immunoassays with novel labeled carbamazepine hapten analogues
US07/926,203 US5543311A (en) 1992-08-07 1992-08-07 Labeled carbamazepine hapten analogues for competitive enzyme immunoassays

Publications (1)

Publication Number Publication Date
ATE161962T1 true ATE161962T1 (de) 1998-01-15

Family

ID=27129920

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93202292T ATE161962T1 (de) 1992-08-07 1993-08-04 Immunoassays unter verwendung von, mit meerrettich-peroxidase markierten carbamazepin- analogen

Country Status (5)

Country Link
EP (1) EP0584854B1 (de)
JP (1) JP3022942B2 (de)
AT (1) ATE161962T1 (de)
DE (1) DE69316112T2 (de)
HK (1) HK1011082A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5688944A (en) * 1995-06-07 1997-11-18 Dade International Inc. Carbamazepine derivatives
US6368814B1 (en) * 2000-12-22 2002-04-09 Roche Diagnostics Corporation Tricyclic antidepressant derivatives and immunoassay
GB201110164D0 (en) 2011-06-16 2011-07-27 Randox Lab Ltd Sensitive and generic antibodies with multiple applications

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4058511A (en) * 1976-01-12 1977-11-15 Syva Company Tegretol antigens and antibodies
JPS54119026A (en) * 1978-03-06 1979-09-14 Dainippon Pharmaceut Co Ltd Simultaneous enzyme immunoassay and kit for practicing the same
JPS57109724A (en) * 1980-12-26 1982-07-08 Chugai Pharmaceut Co Ltd Novel hapten antigen and its preparation
US4874692A (en) * 1987-07-20 1989-10-17 Eastman Kodak Company Binder composition and analytical element having stabilized peroxidase in layer containing the composition
CA2013014A1 (en) * 1989-11-30 1991-05-31 Linda A. Mauck Dry immunoassay analytical element comprising monodispersed beads
US5200315A (en) * 1990-07-25 1993-04-06 Eastman Kodak Company Particulate biologically active reagent containing polyoxyalkylene side chains, analytical element and methods for use of the reagent
EP0517327B1 (de) * 1991-06-07 2001-08-16 Johnson & Johnson Clinical Diagnostics, Inc. Immunoassays unter Verwendung von markierten Hapten-Analogen
CA2062176A1 (en) * 1991-06-07 1992-12-08 Glen M. Dappen Use of the gravure process for coating thin film layers

Also Published As

Publication number Publication date
JP3022942B2 (ja) 2000-03-21
DE69316112D1 (de) 1998-02-12
EP0584854A1 (de) 1994-03-02
EP0584854B1 (de) 1998-01-07
HK1011082A1 (en) 1999-07-02
JPH06206870A (ja) 1994-07-26
DE69316112T2 (de) 1998-06-10

Similar Documents

Publication Publication Date Title
ATE239790T1 (de) Antikörper gegen cd40-l
FI942432A0 (fi) Järjestely hissikoneiston liittämiseksi rakennukseen
ATE315228T1 (de) Immunoassay zum bestimmen von bnp
ATE199263T1 (de) Für den chemilumineszenz-nachweis verwendbare aryl-n-alkylacridanthiocarboxylat-derivate
DE68922243T2 (de) Immuntest für HIV-1-Antigene unter Benutzung von F(AB')2-Fragmenten als Sonde.
ES2132174T3 (es) Reactivo liquido de tromboplastina.
FI954029A (fi) Kemiluminesoiva reagenssi ja analyysimenetelmä, jossa käytetään substituoitua asetanilidia valon muodostukseen
ATE204385T1 (de) Immunoassays unter verwendung von markierten hapten-analogen
DK603087A (da) Immunokemisk metod tilbestemmelse af stabilt glycosyleret haemoglobin
ATE161962T1 (de) Immunoassays unter verwendung von, mit meerrettich-peroxidase markierten carbamazepin- analogen
IT8720644A0 (it) Abbaino, in particolare per un dispositivo di regolazione, lucernaio a cupola. sensibile ad almeno un influsso ambientale, per il coperchio supportato a cerniera di un
DE69738503D1 (de) Den nachweis von oxidierten und mda-modifizierten lipoproteinen geringer dichte
DK610184D0 (da) Fremgangsmaade til paavisning af allergenholdigt husstoev
DK0994121T3 (da) Forgrenede peptider i analyser for antistoffer
SG64299A1 (en) Dry analytical element for lithium assay
ATE114818T1 (de) Immuntest zum nachweis von alpha-haloacetamiden.
IT8819788A0 (it) Microreazioni chimiche e relativo dispositivo atto a realizzare procedimento. determinazioni fotometriche e spettrofometriche nonche'
DE68923729D1 (de) Filmbehälter für entwickelten photographischen Film.
DE58909089D1 (de) Verwendung von Myricetin-3-0-beta-D-glucuronid als Arzneimittel.
FI915510A0 (fi) Analytiska element som innehaoller icke-reagerande blockerande faergaemne.
DE69113298D1 (de) Kalibrierungsmethode von Systemen für Enzymimmuntests.
DE3880277T2 (de) Lichtempfindliches elektrophotographisches material.
KR900007157U (ko) 청사진 복사기의 현상액 도포장치
SE8902698D0 (sv) Baerregel foer takpannor
FI871804A0 (fi) Foerfarande foer kontrollering av indirekt processmaetning medelst ur processen tagna prov samt i foerfarandet anvaendbar apparatur.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties